Immuneering | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Citadel Advisors LLC(0.0%),Citadel Advisors Holdings LP(0.0%), etc.
Immuneering | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Cormorant Asset Management, LP(0%),Bihua Chen(0%)
Immuneering | 4: Statement of changes in beneficial ownership of securities-Officer Morales Mallory
Immuneering | 4: Statement of changes in beneficial ownership of securities-Director Schall Thomas J.
Immuneering | 4: Statement of changes in beneficial ownership of securities-Director Feinberg Peter
Immuneering | 4: Statement of changes in beneficial ownership of securities-Director KEATING LAURIE
Immuneering | 4: Statement of changes in beneficial ownership of securities-Director CARPENTER ROBERT J
Immuneering | 4: Statement of changes in beneficial ownership of securities-Director BERMAN ANN E
Immuneering | 4: Statement of changes in beneficial ownership of securities-Director HAUSMAN DIANA
Immuneering | 4: Statement of changes in beneficial ownership of securities-Officer Bookman Michael
Immuneering | 4: Statement of changes in beneficial ownership of securities-Officer Brakewood Harold Eugene
Immuneering | 4: Statement of changes in beneficial ownership of securities-Officer Neufeld Leah R
Immuneering | 4: Statement of changes in beneficial ownership of securities-Officer Morales Mallory
Immuneering | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Cormorant Asset Management, LP(5.81%),Bihua Chen(5.81%), etc.
Immuneering | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. ROWE PRICE ASSOCIATES, INC.(3.1%)
Immuneering | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(4.7%)
Immuneering | 4: Statement of changes in beneficial ownership of securities-10% Owner Cormorant Asset Management, LP
Immuneering | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Merrin Investors LLC(9.46%)
Immuneering | 4: Statement of changes in beneficial ownership of securities-Director Schall Thomas J.
Immuneering | 4: Statement of changes in beneficial ownership of securities-Director Feinberg Peter
No Data
No Data